[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.

Kamada Ltd (KMDA)

Kamada Ltd (KMDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 474,991
  • Shares Outstanding, K 57,505
  • Annual Sales, $ 180,460 K
  • Annual Income, $ 20,200 K
  • EBIT $ 28 M
  • EBITDA $ 43 M
  • 60-Month Beta 0.86
  • Price/Sales 2.67
  • Price/Cash Flow 13.72
  • Price/Book 1.79

Options Overview Details

View History
  • Implied Volatility 144.07% (+1.24%)
  • Historical Volatility 33.25%
  • IV Percentile 15%
  • IV Rank 23.65%
  • IV High 545.63% on 09/12/25
  • IV Low 19.65% on 09/02/25
  • Expected Move (DTE 21) 0.00 (0.00%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 28
  • Put/Call OI Ratio 0.20
  • Today's Open Interest 290
  • Open Int (30-Day) 204
  • Expected Range 8.29 to 8.29

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $0.14
  • Number of Estimates 3
  • High Estimate $0.16
  • Low Estimate $0.12
  • Prior Year $0.09
  • Growth Rate Est. (year over year) +55.56%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.85 +21.02%
on 08/12/26
8.64 -4.05%
on 08/26/26
+1.23 (+17.42%)
since 07/28/26
3-Month
6.85 +21.02%
on 08/12/26
8.64 -4.05%
on 08/26/26
+0.43 (+5.47%)
since 05/28/26
52-Week
6.50 +27.54%
on 10/07/25
9.35 -11.34%
on 02/25/26
+1.27 (+18.09%)
since 08/28/25

Most Recent Stories

More News
Kamada Declares Cash Dividend of $0.17 Per Share; The Company Reported Record-High Revenue and Profitability for First Six Months of 2026

Dividend to be Paid Consistent with the Company's Cash Dividend Policy

KMDA : 8.29 (+0.36%)
Kamada: Q2 Earnings Snapshot

Kamada: Q2 Earnings Snapshot

KMDA : 8.29 (+0.36%)
Kamada Reports Record-High First Half and Second Quarter 2026 Financial Results, Representing Double-Digit Profitable Growth and the Strongest in Kamada's History; Affirms 2026 Annual Guidance

REHOVOT, Israel and HOBOKEN, N.J., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for...

KMDA : 8.29 (+0.36%)
Kamada Announces Planned Transition of Chief Financial Officer

REHOVOT, Israel, and HOBOKEN, N.J., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with...

KMDA : 8.29 (+0.36%)
Kamada to Announce Second Quarter and First Half Ended June 30, 2026 Financial Results on August 12, 2026

Company to Host Conference Call at 8:30am ET

KMDA : 8.29 (+0.36%)
Kamada Announces a Three-Year $50 Million Sales Agreement to Supply Plasma to a Leading Biopharmaceutical Company focused on Plasma-derived Therapies

REHOVOT, Israel and HOBOKEN, N.J., July 20, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a...

KMDA : 8.29 (+0.36%)
Kamada Highlights CYTOGAM® Study Results Presented at the 2026 ISHLT Annual Meeting

Findings from analyses of CMV high-risk lung transplant recipients suggest CYTOGAM use is associated with improved clinical outcomes, supporting increased...

KMDA : 8.29 (+0.36%)
Kamada Announces FDA Approval of its New In-House Rabies Virus Neutralization Testing Laboratory

REHOVOT, Israel and HOBOKEN, N.J., June 01, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with...

KMDA : 8.29 (+0.36%)
Kamada Q1 Earnings Call Highlights

Kamada (NASDAQ:KMDA) reiterated its full-year 2026 outlook after reporting first-quarter results that management said were in line with expectations, excluding a temporary shipment delay that shifted revenue...

KMDA : 8.29 (+0.36%)
Kamada: Q1 Earnings Snapshot

Kamada: Q1 Earnings Snapshot

KMDA : 8.29 (+0.36%)

Business Summary

Kamada Ltd. is a biopharmaceutical company. It develops, produces and markets therapeutics based on chromatographic purification technology. The company offers bio-therapeutics for specialty proteins, specific immunoglobulins and other prescription medicines. Kamada Ltd. is headquartered in Ness Ziona,...

See More

Key Turning Points

3rd Resistance Point 8.46
2nd Resistance Point 8.40
1st Resistance Point 8.35
Last Price 8.29
1st Support Level 8.24
2nd Support Level 8.18
3rd Support Level 8.13

See More

52-Week High 9.35
Last Price 8.29
Fibonacci 61.8% 8.26
Fibonacci 50% 7.93
Fibonacci 38.2% 7.59
52-Week Low 6.50

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.